Appearance and disappearance of neutralizing antibodies during interferon-beta therapy

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

  • P Soelberg Sorensen
  • Nils Koch-Henriksen
  • Pedersen, Christian Ross
  • K M Clemmesen
  • K Bendtzen
  • Danish Multiple Sclerosis Study Group
Neutralizing antibodies (NABs) occur frequently in patients receiving interferon (IFN)-beta for multiple sclerosis (MS), but it is unclear whether occurrence of NABs is predictive for the persistence of NABs during continued IFN-beta therapy.
OriginalsprogEngelsk
TidsskriftNeurology
Vol/bind65
Udgave nummer1
Sider (fra-til)33-9
Antal sider7
ISSN0028-3878
DOI
StatusUdgivet - 12 jul. 2005

ID: 34102301